Transgenerational Transmission of Reproductive and Metabolic Dysfunction in the Male Progeny of Polycystic Ovary Syndrome
Sanjiv Risal,Congru Li,Qing Luo,Romina Fornes,Haojiang Lu,G. Eriksson,Maria Manti,Claes Ohlsson,Eva Lindgren,Nicolás Crisosto,Manuel Maliqueo,Bárbara Echiburú,Sergio E. Recabarren,Teresa Sir Petermann,Anna Benrick,Nele Brusselaers,Jie Qiao,Qiaolin Deng,Elisabet Stener‐Victorin
DOI: https://doi.org/10.2139/ssrn.4133891
2022-01-01
SSRN Electronic Journal
Abstract:Polycystic ovary syndrome (PCOS), affecting ~15% of women at reproductive age worldwide, is a highly heritable disorder and linked to comorbidities such as infertility, type-2 diabetes, psychiatric disorders, and cancer. Moreover, there are now indications that a male equivalent of PCOS may exist. The transgenerational maternal effects of polycystic ovary syndrome (PCOS) in female progeny have started to be revealed. One unexplored question is whether sons born to mother with PCOS (PCOS-sons) transmit reproductive and metabolic phenotypes to their male progeny. Here, in a Swedish nationwide register-based cohort and a clinical case-control study from Chile we found that PCOS-sons are more often obese and dyslipidemic. Moreover, whole blood miRNAs from PCOS-sons are found to potentially regulate PCOS-risk genes. Our PCOS-like mouse model induced by late gestation injection of dihydrotestosterone (F0) with or without diet-induced obesity confirmed that reproductive and metabolic dysfunctions in first-generation male offspring are passed down to third-generation. Small non-coding RNAs (sncRNAs) sequencing of sperm revealed distinct differentially expressed (DE) sncRNAs across generations in the androgenized, obese, and obese and androgenized lineages, respectively. Notably, there are several common targets between transgenerational DEsncRNAs in mouse sperm and DEsncRNAs in whole blood from PCOS-sons providing first evidence of conserved effects. These findings strengthen the translational relevance and shed light on a previously underappreciated risk of reproductive and metabolic dysfunction across generations via the male germline and identify possible molecular markers for prediction of transmission of disease in future generations.Funding Information: Swedish Medical Research Council: project no. 2018-02435 (ESV), 2018-02557 and 2020-00253 (QD) Knut and Alice Wallenberg Foundation: 2019.0211 (QD) Distinguished Investigator Grant – Endocrinology and Metabolism, Novo Nordisk Foundation: NNF22OC0072904 (ESV) Novo Nordisk Foundation: NNF18OC0033992 and NNF19OC0056647 (ESV) Strategic Research Program in Diabetes at the Karolinska Institutet (ESV) Adlerbertska Research Foundation: GU 2019/86 (ESV) Karolinska Institutet KID funding: 2020-00990 (ESV) Karolinska Instiutet faculty funded position (QD) Regional Agreement on Medical Training and Clinical Research between the Stockholm County Council and the Karolinska Institutet: 20190079 (ESV) O. E. och Edla Johanssons Stiftelse 2021 (SR)Karolinska Institutet-China scholarship council programme (QL) Magnus Bergvalls Stiftelse-Research grant (2020-03808) (SR) Karolinska Institutet, Sweden-Research grant (2020-02026) (SR) National Fund for Scientific and Technological Development (FONDECYT) project no. 1151531 (TSP) FONDECYT project no. 1201483 (BE) National Commission for Scientific and Technological Research (CONICYT) (RF) HKH Kronprinsessan Lovisas förening för barnasjukvård (RF) Stiftelsen Axel Tielmans minnesfond Lovisas (RF)Declaration of Interests: Authors declare that they have no competing interests.Ethics Approval Statement: All procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. The register-based study was approved by the regional ethical review board in Stockholm, Sweden (diary number 2017/2423-31). The requirement for informed consent was waived because of the nature of this study, and the included individuals were not identifiable at any time. The case-control protocol was approved by the institutional review board of the University of Chile (Approval of Research Project No.032-2015). All parents signed informed consent, and boys gave their assent before any examination. All animal experiments were approved by the Stockholm Ethical Committee for Animal Research (10798-2017) by the legal requirements of the European Community (SJVFS 2017:40) and the directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes. Animal care and procedures were performed following guidelines specified by the European Council Directive and controlled by Comparative Medicine Biomedicum (KM-B), Karolinska Institutet, Stockholm, Sweden.